Free Newsletter
SPOTLIGHT: Abbott edges Genentech in CEO tourney
Free newsletter via e-mail
Tools
Remember the Pharma CEO tournament bracket the Wall Street Journal Health Blog came up with a few weeks ago? Well, the competition was fierce, but the predictions are in. The chosen winner? Miles White (photo), CEO of Abbott Labs, who won by a nose over Genentech CEO Art Levinson (photo). White got 40 percent of 12,000 votes compared with Levinson's 39 percent. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
